National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 7618-7619 [E9-3430]
Download as PDF
7618
Federal Register / Vol. 74, No. 31 / Wednesday, February 18, 2009 / Notices
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Anemia.
Date: March 10, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway, 7201 Wisconsin Ave., 2C212,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Alicja L Markowska, PhD,
DSC, Scientific Review Officer, Scientific
Review Branch, National Institute On Aging,
7201 Wisconsin Avenue, Suite 2C212,
Bethesda, MD 20892, 301–496–9666,
markowsa@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, EUREKA.
Date: March 23, 2009.
Time: 12 p.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Chief, Scientific Review Branch, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C–
212, Bethesda, MD 20892, 301–402–7700,
rv23r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
Jkt 217001
Dated: February 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–3420 Filed 2–17–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
BILLING CODE 4140–01–P
17:45 Feb 17, 2009
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Population Research
Infrastructure Program.
Date: March 13, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Rennaissance Mayflower Hotel,
1127 Connecticut Avenue NW., Washington,
DC.
Contact Person: Marita R. Hopmann, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health, and Human Development, 6100
Building, Room 5B01, Bethesda, MD 20892,
(301) 435–6911, hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
National Institutes of Health
Dated: February 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–3317 Filed 2–17–09; 8:45 am]
VerDate Nov<24>2008
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review U13, Conference
Cooperative Agreement.
Date: April 15, 2009.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6706
Democracy Blvd., Bethesda, MD 20892,
(Telephone Conference Call).
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Contact Person: Mary Kelly, Scientific
Review Officer, Scientific Review Branch,
National Inst of Dental & Craniofacial
Research, NIH 6701 Democracy Blvd, Room
672, MSC 4878, Bethesda, MD 20892–4878,
301–594–4809, mary_kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: February 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–3421 Filed 2–17–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trails.
Date: March 13, 2009.
Time: 2 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/National Institutes of Health/NIAID,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892–7616, 301–402–7098,
pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\18FEN1.SGM
18FEN1
Federal Register / Vol. 74, No. 31 / Wednesday, February 18, 2009 / Notices
Dated: February 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–3430 Filed 2–17–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Extension of Agency Information
Collection Activity Under OMB Review:
Department of Homeland Security—
Vulnerability Identification SelfAssessment Tool—Transportation
(DHS–VISAT–T)
AGENCY: Transportation Security
Administration, DHS.
ACTION: 30 day Notice.
This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
OMB control number 1652–0037,
abstracted below to the Office of
Management and Budget (OMB) for
review and approval of an extension of
the currently approved collection under
the Paperwork Reduction Act. The ICR
describes the nature of the information
collection and its expected burden. TSA
published a Federal Register notice,
with a 60-day comment period soliciting
comments, of the following collection of
information on December 24, 2008, 73
FR 79148. The collection allows TSA to
collect data from transportation asset
owners or operators on security
measures deployed and their
effectiveness.
DATES: Send your comments by March
20, 2009. A comment to OMB is most
effective if OMB receives it within 30
days of publication.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to Desk Officer, Department of
Homeland Security/TSA, and sent via
electronic mail to
oira_submission@omb.eop.gov or faxed
to (202) 395–6974.
FOR FURTHER INFORMATION CONTACT:
Ginger LeMay, Office of Information
Technology, TSA–11, Transportation
Security Administration, 601 South
12th Street, Arlington, VA 20598–6011;
telephone (571) 227–3616; e-mail
ginger.lemay@dhs.gov.
SUPPLEMENTARY INFORMATION:
mstockstill on PROD1PC66 with NOTICES
SUMMARY:
VerDate Nov<24>2008
17:45 Feb 17, 2009
Jkt 217001
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation is
available at https://www.reginfo.gov.
Therefore, in preparation for OMB
review and approval of the following
information collection, TSA is soliciting
comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Information Collection Requirement
Title: Department of Homeland
Security—Vulnerability Identification
Self-Assessment Tool—Transportation
(DHS–VISAT–T).
Type of Request: Extension of a
currently approved collection.
OMB Control Number: 1652–0037.
Forms(s): NA.
Affected Public: Transportation
Sectors.
Abstract: The DHS–VISAT–T
(formerly the TSA Self-Assessment Risk
Module (TSARM)) was developed to
assist all modes of transportation asset
owners/operators in developing a
security plan and in performing a
vulnerability assessment of their
asset(s). The tool is designed to be userfriendly, web-based, and is provided at
no cost to transportation owner and
operators. The tool captures a snapshot
of the asset’s baseline security posture
and assists the stakeholder in
conducting a vulnerability assessment
and completing a comprehensive
security plan. TSA designed this tool to
be flexible to support the unique
characteristics of each transportation
mode, while still providing a common
framework from which analysis and
trends can be identified. Thus far, TSA
has developed modules of the tool for
maritime, mass transit, highway bridges,
and rail passenger stations, with more in
development.
Users have the option to submit the
completed assessment to TSA. If
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
7619
submitted, TSA reviews the assessment
for consistency and provides feedback
to the users. Submitted assessments are
then used to conduct analysis of the
industry standard and to provide cross
sector analysis of multiple modes.
Number of Respondents: 1,000.
Estimated Annual Burden Hours: An
estimated 8,000 hours annually.
Issued in Arlington, Virginia, on
February 12, 2009.
Ginger LeMay,
Paperwork Reduction Act Officer, Business
Improvements and Communications, Office
of Information Technology.
[FR Doc. E9–3443 Filed 2–17–09; 8:45 am]
BILLING CODE 9110–05–P
DEPARTMENT OF LABOR
Employment Standards Administration
Proposed Extension of the Approval of
Information Collection Requirements
ACTION:
Notice.
SUMMARY: The Department of Labor
(DOL), as part of its continuing effort to
reduce paperwork and respondent
burden, conducts a preclearance
consultation program to provide the
general public and Federal agencies
with an opportunity to comment on
proposed and/or continuing collections
of information in accordance with the
Paperwork Reduction Act of 1995
(PRA95) [44 U.S.C. 3506(c)(2)(A)]. This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employment Standards Administration
is soliciting comments concerning its
proposal to extend OMB approval of the
information collection: Regulations
Governing the Administration of the
Longshore and Harbor Workers’
Compensation Act (ESA–100, LS–200,
LS–201, LS–203, LS–204, LS–262, LS–
267, LS–271, LS–274, LS–513). A copy
of the proposed information collection
request can be obtained by contacting
the office listed below in the addresses
section of this Notice.
DATES: Written comments must be
submitted to the office listed in the
addresses section below on or before
April 20, 2009.
ADDRESSES: Mr. Steven D. Lawrence,
U.S. Department of Labor, 200
Constitution Ave., NW., Room S–3201,
Washington, DC 20210, telephone (202)
693–0292, fax (202) 693–1451, E-mail
E:\FR\FM\18FEN1.SGM
18FEN1
Agencies
[Federal Register Volume 74, Number 31 (Wednesday, February 18, 2009)]
[Notices]
[Pages 7618-7619]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3430]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trails.
Date: March 13, 2009.
Time: 2 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, DHHS/
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892-7616, 301-402-7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 7619]]
Dated: February 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-3430 Filed 2-17-09; 8:45 am]
BILLING CODE 4140-01-P